A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties
- PMID: 17698276
- DOI: 10.1016/j.fct.2007.05.015
A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties
Abstract
Quercetin is a naturally-occurring flavonol (a member of the flavonoid family of compounds) that has a long history of consumption as part of the normal human diet. Because a number of biological properties of quercetin may be beneficial to human health, interest in the addition of this flavonol to various traditional food products has been increasing. Prior to the use of quercetin in food applications that would increase intake beyond that from naturally-occurring levels of the flavonol in the typical Western diet, its safety needs to be established or confirmed. This review provides a critical examination of the scientific literature associated with the safety of quercetin. Results of numerous genotoxicity and mutagenicity, short- and long-term animal, and human studies are reviewed in the context of quercetin exposure in vivo. To reconcile results of in vitro studies, which consistently demonstrated quercetin-related mutagenicity to the absence of carcinogenicity in vivo, the mechanisms that lead to the apparent in vitro mutagenicity, and those that ensure absence of quercetin toxicity in vivo are discussed. The weight of the available evidence supports the safety of quercetin for addition to food.
Similar articles
-
Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Food Chem Toxicol. 2008. PMID: 18328408 Review.
-
Safety of quercetin for clinical application (Review).Int J Mol Med. 2005 Aug;16(2):275-8. Int J Mol Med. 2005. PMID: 16012761 Review.
-
Evaluation of the potential in vivo genotoxicity of quercetin.Mutat Res. 2008 Jun 30;654(1):38-44. doi: 10.1016/j.mrgentox.2008.04.008. Epub 2008 May 2. Mutat Res. 2008. PMID: 18556240
-
Final report on the safety assessment of 3-methylamino-4-nitrophenoxyethanol as used in hair dyes.Int J Toxicol. 2008;27 Suppl 2:41-51. doi: 10.1080/10915810802244488. Int J Toxicol. 2008. PMID: 18830863
-
Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk.Mutat Res. 2005 Jul 1;574(1-2):124-38. doi: 10.1016/j.mrfmmm.2005.01.028. Epub 2005 Mar 31. Mutat Res. 2005. PMID: 15914212 Review.
Cited by
-
Mango leaf extract improves central pathology and cognitive impairment in a type 2 diabetes mouse model.Brain Pathol. 2017 Jul;27(4):499-507. doi: 10.1111/bpa.12433. Epub 2016 Nov 24. Brain Pathol. 2017. PMID: 27537110 Free PMC article.
-
Pharmacological and mechanistic aspects of quercetin in osteoporosis.Front Pharmacol. 2024 Jan 25;15:1338951. doi: 10.3389/fphar.2024.1338951. eCollection 2024. Front Pharmacol. 2024. PMID: 38333006 Free PMC article. Review.
-
Development and evaluation of quercetin enriched bentonite-reinforced starch-gelatin based bioplastic with antimicrobial property.Saudi Pharm J. 2023 Dec;31(12):101861. doi: 10.1016/j.jsps.2023.101861. Epub 2023 Nov 2. Saudi Pharm J. 2023. PMID: 38028210 Free PMC article.
-
Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19-Results From a Pilot Open-Label, Randomized Controlled Trial.Front Pharmacol. 2022 Jun 7;13:898062. doi: 10.3389/fphar.2022.898062. eCollection 2022. Front Pharmacol. 2022. PMID: 35747751 Free PMC article.
-
Research Progress of Tamarixetin and its Glycosides.Mini Rev Med Chem. 2024;24(7):689-703. doi: 10.2174/1389557523666230828123425. Mini Rev Med Chem. 2024. PMID: 37642001 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical